Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 88, No. 2, 2005   

Free Abstract     Article (References)     Article (PDF 88 KB)     

Case Report

Oral Sildenafil for Treatment of Severe Pulmonary Hypertension in an Infant
Kam-lun Ellis Hona, Kam-lau Cheunga, Kiu-lok Siub, Ting-fan Leunga, Man-ching Yama, Tai-fai Foka, Pak-cheung Nga

aDepartment of Paediatrics, Prince of Wales Hospital, Chinese University of Hong Kong, Shatin, and
bDepartment of Paediatrics, Queen Elizabeth Hospital, Kowloon, Hong Kong, SAR, China

Address of Corresponding Author

Biol Neonate 2005;88:109-112 (DOI: 10.1159/000085646)


 goto top of page Key Words

  • Sildenafil
  • Bronchopulmonary dysplasia
  • Pulmonary arterial hypertension

 goto top of page Abstract

We report the use of oral sildenafil in a 5-month-old preterm infant with severe bronchopulmonary dysplasia and pulmonary arterial hypertension refractory to inhaled nitric oxide treatment, maximal ventilatory support and conventional vasodilator therapy. Sildenafil was prepared as a liquid suspension by the method of trituration and administered via an orogastric tube to the patient. Forty-eight hours after sildenafil treatment, echocardiography revealed that the tricuspid incompetence was substantially diminished and the contractility of both ventricles improved, indicating a marked reduction in pulmonary arterial pressure. Oral sildenafil treatment was continued for 6 months until complete resolution of pulmonary arterial hypertension, and oxygen supplement was weaned off. There was no adverse effect during the treatment period. Oral sildenafil may be useful in reducing pulmonary vascular resistance and can be considered for treatment of severe pulmonary arterial hypertension secondary to bronchopulmonary dysplasia.

Copyright © 2005 S. Karger AG, Basel


 goto top of page Author Contacts

Prof. Pak-cheung Ng
Department of Paediatrics, Prince of Wales Hospital
6/F, Clinical Sciences Building, Chinese University of Hong Kong
Shatin, Hong Kong, SAR (China)
Tel. +852 2632 2851, Fax +852 2636 0020, E-Mail pakcheungng@cuhk.edu.hk


 goto top of page Article Information

Received: November 29, 2004
Accepted after revision: January 18, 2005
Published online: May 4, 2005
Number of Print Pages : 4
Number of Figures : 1, Number of Tables : 0, Number of References : 17

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 15870496)
Download Citation
Cited In




For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.




copyright  © 2009 S. Karger AG, Basel